A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients

  1. Sauter, C.S.
  2. Barker, J.N.
  3. Lechner, L.
  4. Zheng, J.
  5. Devlin, S.M.
  6. Papadopoulos, E.B.
  7. Perales, M.-A.
  8. Jakubowski, A.A.
  9. Goldberg, J.D.
  10. Koehne, G.
  11. Ceberio, I.
  12. Giralt, S.
  13. Zelenetz, A.D.
  14. Moskowitz, C.H.
  15. Castro-Malaspina, H.
Aldizkaria:
Biology of Blood and Marrow Transplantation

ISSN: 1083-8791,  1523-6536

Argitalpen urtea: 2014

Alea: 20

Zenbakia: 3

Orrialdeak: 354-360

Mota: Artikulua

DOI: 10.1016/J.BBMT.2013.11.029 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus